Santiago Perez-Lloret Selected Research

Multiple System Atrophy

1/2021	Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial.
5/2014	A cross-sectional study on drug use in multiple system atrophy.
1/2009	Does clinical intolerance to a diagnostic acute levodopa challenge differentiate multiple system atrophy from PD?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Santiago Perez-Lloret Research Topics

Disease

29	Parkinson Disease (Parkinson's Disease) 11/2020 - 03/2009
10	Dyskinesias (Dyskinesia) 01/2020 - 07/2011
6	Orthostatic Hypotension (Postural Hypotension) 01/2018 - 07/2011
4	Hallucinations (Hallucination) 01/2020 - 09/2010
4	Nausea 01/2018 - 01/2009
4	Constipation 01/2018 - 10/2011
4	Cognitive Dysfunction 12/2016 - 08/2015
4	Drug-Related Side Effects and Adverse Reactions 10/2011 - 09/2010
3	Multiple System Atrophy 01/2021 - 01/2009
3	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2017 - 09/2010
3	Dementia (Dementias) 12/2016 - 10/2011
3	Psychotic Disorders (Schizoaffective Disorder) 12/2016 - 10/2011
3	Hypotension (Low Blood Pressure) 03/2015 - 01/2009
3	Parkinsonian Disorders (Parkinsonism) 03/2015 - 10/2011
3	Sialorrhea 01/2015 - 10/2011
3	Vomiting 07/2011 - 01/2009
2	Movement Disorders (Movement Disorder) 09/2018 - 01/2016
2	Delirium 01/2018 - 01/2016
2	Confusion (Bewilderment) 01/2018 - 09/2010
2	Fatigue 01/2018 - 10/2011
2	Sleepiness 06/2016 - 09/2010
2	Dystonia (Limb Dystonia) 09/2014 - 06/2012
2	Erectile Dysfunction 03/2013 - 10/2011
2	Restless Legs Syndrome (Restless Legs) 02/2013 - 12/2012
2	Neuralgia (Stump Neuralgia) 06/2012 - 01/2012
2	Pain (Aches) 06/2012 - 01/2012
1	COVID-19 05/2022
1	Myocarditis (Carditis) 05/2022
1	Pericarditis 05/2022
1	Wounds and Injuries (Trauma) 01/2020
1	Depressive Disorder (Melancholia) 09/2018
1	Livedo Reticularis 01/2018
1	Edema (Dropsy) 01/2018
1	Anosmia 08/2015
1	Major Depressive Disorder (Major Depressive Disorders) 08/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2015
1	Ataxia (Dyssynergia) 03/2015
1	Cerebellar Ataxia (Dysmetria) 03/2015
1	Tremor (Tremors) 09/2014
1	Fibrosis (Cirrhosis) 03/2014

Drug/Important Bio-Agent (IBA)

19	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 01/2009
8	Dopamine Agonists (Dopamine Agonist)IBA 05/2016 - 03/2009
7	Pharmaceutical PreparationsIBA 11/2020 - 11/2010
4	Amantadine (Aman)FDA LinkGeneric 01/2020 - 10/2011
4	Antipsychotic Agents (Antipsychotics)IBA 09/2018 - 10/2011
4	Pramipexole (Mirapex)FDA LinkGeneric 03/2014 - 09/2010
3	Dopamine (Intropin)FDA LinkGeneric 12/2016 - 11/2012
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2015 - 10/2011
3	rotigotine FDA Link 02/2013 - 03/2009
2	Fluoxetine (Prozac)FDA LinkGeneric 01/2021 - 10/2011
2	Delayed-Action PreparationsIBA 01/2020 - 09/2015
2	Donepezil (Aricept)FDA LinkGeneric 12/2016 - 10/2011
2	EnzymesIBA 12/2016 - 01/2016
2	Cholinergic Agents (Cholinergics)IBA 12/2016 - 01/2016
2	Rivastigmine (Exelon)FDA LinkGeneric 12/2016 - 10/2011
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2016 - 01/2015
2	Type A Botulinum Toxins (Botox)FDA Link 03/2015 - 10/2011
2	Apomorphine FDA Link 03/2015 - 06/2012
2	Lubiprostone FDA Link 03/2015 - 03/2013
2	Tropicamide FDA LinkGeneric 01/2015 - 03/2013
2	amsonic acid (DAS)IBA 03/2014 - 09/2010
2	Botulinum Toxins (Botulinum Toxin)IBA 03/2013 - 06/2012
2	Sildenafil Citrate (Viagra)FDA Link 03/2013 - 10/2011
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 03/2013 - 10/2011
2	hydroxide ionIBA 03/2013 - 06/2012
2	Antidepressive Agents (Antidepressants)IBA 12/2012 - 10/2011
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 06/2012 - 10/2011
2	Analgesics (Analgesic Drugs)IBA 06/2012 - 01/2012
2	Pergolide (Permax)FDA Link 10/2011 - 09/2010
1	COVID-19 VaccinesIBA 05/2022
1	Messenger RNA (mRNA)IBA 05/2022
1	VaccinesIBA 05/2022
1	CateninsIBA 01/2020
1	propylene diquat (PDQ(+))IBA 01/2020
1	Perindopril FDA LinkGeneric 10/2017
1	Cholinesterases (Cholinesterase)IBA 12/2016
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2016
1	Investigational DrugsIBA 01/2016
1	AcetylcholinesteraseIBA 01/2016
1	Neuroprotective AgentsIBA 01/2016
1	Muscarinic AntagonistsIBA 01/2016
1	safinamideIBA 01/2016
1	Piribedil (Trivastal)IBA 01/2016
1	Mesylates (Mesylate)IBA 01/2016
1	DiureticsIBA 10/2015
1	N-Methylaspartate (NMDA)IBA 09/2015
1	N 30IBA 08/2015
1	DroxidopaIBA 03/2015
1	Midodrine (Midon)FDA LinkGeneric 03/2015
1	tozadenantIBA 06/2014
1	Purinergic P1 Receptor AntagonistsIBA 06/2014
1	istradefyllineIBA 06/2014

Therapy/Procedure

8	Therapeutics 01/2020 - 01/2010
2	Injections 03/2015 - 01/2015
2	Transcranial Magnetic Stimulation 06/2012 - 10/2011
1	Diet Therapy (Therapy, Diet) 01/2017
1	Drug Therapy (Chemotherapy) 12/2016
1	Activities of Daily Living (ADL) 03/2015
1	Psychology Biofeedback (Biofeedback) 03/2015
1	Operative Surgical Procedures 01/2015